Sandu Pharmaceuticals Ltd.
BSE: 524703
₹37.48
₹-0.98
(-2.55%)
As on 13-May-2026IST
Market cap
₹36 Cr
Revenue (TTM)
₹70 Cr
P/E Ratio
20.4
P/B Ratio
1
Div. Yield
2.7 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2 Cr
-
ROE
4.7 %
-
ROCE
6.9 %
-
Industry P/E
51.79
-
EV/EBITDA
8.5
-
Debt to Equity
0
-
Book Value
₹36.3
-
EPS
₹1.8
-
Face value
10
-
Shares outstanding
9,660,990
10 Years Aggregate
CFO
₹25.13 Cr
EBITDA
₹23.40 Cr
Net Profit
₹9.26 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sandu Pharma
| 0.1 | 2.7 | 7.0 | -27.6 | -12.5 | -2.1 | 2.1 |
|
BSE Healthcare
| 6.3 | 8.3 | 7.1 | 10.9 | 25.9 | 13.6 | 11.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Sandu Pharma
| -33.5 | -19.6 | 1.8 | -4.6 | 69.0 | 198.9 | -41.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sandu Pharma
|
37.5 | 36.0 | 69.9 | 1.8 | 3.3 | 4.1 | 20.4 | 1.0 |
| 6.2 | 7.4 | 0.5 | -0.1 | -89.9 | -- | -- | 0.6 | |
| 26.0 | 14.8 | 8.0 | 0.6 | 13.8 | 5.5 | 23.5 | 1.2 | |
| 715.5 | 8,891.2 | 469.1 | 90.7 | -- | 39 | 98 | 21.2 | |
| 214.6 | 283.2 | 127.7 | -24.3 | -20.8 | -325.5 | -- | 56.7 | |
| 21.3 | 36.6 | 49.3 | 0.8 | 1.6 | 4.5 | 48.2 | 2.1 | |
| 198.2 | 302.3 | 162.9 | 9.8 | -- | 32.2 | 17.7 | -- | |
| 108.2 | 69.7 | 65.4 | 2.8 | 6.6 | 12.1 | 25 | 2.8 | |
| 262.7 | 259.2 | 89.9 | 7.2 | -- | 13.7 | 36.3 | 4.1 | |
| 36.5 | 34.3 | 71.8 | 2.8 | -- | 18.2 | 14.7 | 2.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Sandu Pharma
Sandu Pharmaceuticals Limited manufactures and markets ayurvedic medicines under the SANDU brand in India and internationally. The company offers medicines in the areas of cardiovascular, endocrine, digestive, genito-urinary, muscular-skeletal,... nervous, male reproductive, and respiratory system. It also provides medicines for gynecological; nutrition; skin; and ear, nose, and throat disorders. The company was founded in 1899 and is based in Mumbai, India. Read more
-
Incorporated
1985
-
Chairman
--
-
Managing Director
--
-
Headquarters
Bardez, Goa
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsCorporate Action-Board approves Dividend
05-May-2026Corporate Action-Board to consider Dividend
27-Apr-2026No News & Announcements are available.
FAQs for Sandu Pharma
What is the current share price of Sandu Pharmaceuticals Ltd Today?
The share price of Sandu Pharmaceuticals Ltd is ₹37.48 (BSE) as of 13-May-2026 IST. Sandu Pharmaceuticals Ltd has given a return of -12.53% in the last 3 years.
What is the current PB & PE ratio of Sandu Pharmaceuticals Ltd?
The P/E ratio of Sandu Pharmaceuticals Ltd is 20.42 times as on 13-May-2026, a 61 discount to its peers’ median range of 51.79 times.
The P/B ratio of Sandu Pharmaceuticals Ltd is 1.03 times as on 13-May-2026, a 97 discount to its peers’ median range of 30.83 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
30.50
|
1.41
|
|
2024
|
37.94
|
1.74
|
|
2023
|
33.17
|
1.29
|
|
2022
|
39.00
|
2.29
|
|
2021
|
23.16
|
1.08
|
What is the 52 Week High and Low of Sandu Pharmaceuticals Ltd?
The 52-week high and low of Sandu Pharmaceuticals Ltd are Rs 58.80 and Rs 30.00 as of 13-May-2026.
What is the market cap of Sandu Pharmaceuticals Ltd?
Sandu Pharmaceuticals Ltd has a market capitalisation of ₹ 36 Cr as on 13-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sandu Pharmaceuticals Ltd?
Before investing in Sandu Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.